XBI position history
The shares of SPDR S&P Biotech ETF (XBI) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 269,500 shares, $24M, 6.3% of portfolio, New
- 2022 Q2: 613,000 shares, $46M, 12.4% of portfolio, Add +127.5%
- 2022 Q3: 566,000 shares, $45M, 12.1% of portfolio, Reduce −7.7%
- 2022 Q4: 566,000 shares, $47M, 13.2% of portfolio
- 2023 Q1: 570,000 shares, $43M, 13.0% of portfolio, Add +0.7%
- 2023 Q2: 565,000 shares, $47M, 12.9% of portfolio, Reduce −0.9%
- 2023 Q3: 565,000 shares, $41M, 12.8% of portfolio
- 2023 Q4: 484,000 shares, $43M, 10.4% of portfolio, Reduce −14.3%
- 2024 Q1: 431,215 shares, $41M, 9.3% of portfolio, Reduce −10.9%
- 2024 Q2: 445,005 shares, $41M, 9.9% of portfolio, Add +3.2%
- 2024 Q3: 401,505 shares, $40M, 9.4% of portfolio, Reduce −9.8%
- 2024 Q4: 397,505 shares, $36M, 9.1% of portfolio, Reduce −1.0%
- 2025 Q1: 404,505 shares, $33M, 9.3% of portfolio, Add +1.8%
- 2025 Q2: 415,505 shares, $34M, 9.5% of portfolio, Add +2.7%
- 2025 Q3: 401,505 shares, $40M, 9.9% of portfolio, Reduce −3.4%
- 2025 Q4: 336,505 shares, $41M, 9.5% of portfolio, Reduce −16.2%
- 2026 Q1: 318,505 shares, $41M, 9.3% of portfolio, Reduce −5.3%
- 2026 Q2: 196,505 shares, $31M, 5.9% of portfolio, Reduce −38.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|